GROUP ONE TRADING, L.P. - TEVA PHARMACEUTICAL INDS LTD ownership

TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624959. A total of 6 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of TEVA PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$18,640,500
+43.6%
1,827,500
+6.0%
0.06%
+50.0%
Q2 2023$12,982,473
-19.9%
1,724,100
-5.8%
0.04%
-27.6%
Q1 2023$16,198,155
-53.9%
1,830,300
-52.5%
0.06%
-29.3%
Q4 2022$35,167,632
+35.8%
3,856,100
+20.1%
0.08%
+60.8%
Q3 2022$25,901,000
-4.7%
3,209,600
-11.2%
0.05%
+18.6%
Q2 2022$27,186,000
-34.1%
3,615,100
-17.8%
0.04%
+4.9%
Q1 2022$41,283,000
-16.0%
4,396,500
-28.3%
0.04%
+5.1%
Q4 2021$49,148,000
+105.2%
6,135,800
+149.5%
0.04%
+50.0%
Q3 2021$23,954,000
+25.4%
2,459,300
+27.5%
0.03%
+13.0%
Q2 2021$19,102,000
+7.0%
1,929,500
+24.7%
0.02%
-11.5%
Q1 2021$17,852,000
-40.8%
1,547,000
-50.5%
0.03%
-50.0%
Q4 2020$30,158,000
+32.6%
3,125,200
+23.8%
0.05%
-26.8%
Q3 2020$22,744,000
-20.1%
2,524,300
+9.4%
0.07%
-45.8%
Q2 2020$28,455,000
-12.7%
2,307,800
-36.4%
0.13%
-50.4%
Q1 2020$32,607,000
-31.4%
3,631,100
-25.1%
0.26%
-18.3%
Q4 2019$47,536,000
+118.1%
4,850,600
+53.1%
0.32%
+83.5%
Q3 2019$21,791,000
+24.8%
3,167,300
+67.4%
0.18%
+11.4%
Q2 2019$17,459,000
+71.8%
1,891,500
+191.9%
0.16%
+39.8%
Q1 2019$10,161,000
-10.4%
648,000
-11.9%
0.11%
+15.3%
Q4 2018$11,340,000
-48.1%
735,400
-27.5%
0.10%
-43.4%
Q3 2018$21,852,000
+13.5%
1,014,500
+28.2%
0.17%
+4.8%
Q2 2018$19,247,000
+12.9%
791,400
-20.7%
0.16%
-4.1%
Q1 2018$17,054,000
-47.2%
997,900
-41.4%
0.17%
-24.2%
Q4 2017$32,279,000
+14.7%
1,703,400
+6.5%
0.23%
-11.3%
Q3 2017$28,151,000
-49.6%
1,599,500
-4.8%
0.26%
-55.9%
Q2 2017$55,820,000
+16.1%
1,680,300
+12.2%
0.58%
+3.6%
Q1 2017$48,064,000
-6.9%
1,497,800
+5.2%
0.56%
+11.8%
Q4 2016$51,624,000
+62.4%
1,424,100
+106.1%
0.50%
+45.2%
Q3 2016$31,788,000
+42.6%
690,900
+55.7%
0.34%
+30.7%
Q2 2016$22,287,000
-6.3%
443,700
-0.2%
0.26%
-21.4%
Q1 2016$23,785,000
-30.1%
444,500
-14.2%
0.34%
-16.4%
Q4 2015$34,008,000
+47.8%
518,100
+27.2%
0.40%
+26.4%
Q3 2015$23,002,000
+126.2%
407,400
+136.7%
0.32%
+123.9%
Q2 2015$10,171,000
+426.7%
172,100
+455.2%
0.14%
+373.3%
Q1 2015$1,931,00031,0000.03%
Other shareholders
TEVA PHARMACEUTICAL INDS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Capital Markets Trading UK LLP 1,779,800$13,384,0000.29%
NATIONAL BANK OF CANADA /FI/ 19,000$14,288,0000.06%
Segantii Capital Management Ltd 2,500$1,880,0000.05%
GROUP ONE TRADING, L.P. 3,615,100$27,186,0000.04%
JANE STREET GROUP, LLC 3,412,800$25,664,0000.01%
SIMPLEX TRADING, LLC 1,303,800$9,804,0000.01%
IMC-Chicago, LLC 537,900$4,045,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TEVA PHARMACEUTICAL INDS LTD shareholders